Press release Truffle Capital appoints François Romaneix, former deputy CEO of Institute Pasteur as Senior Partner September 15, 2025 Download PDF
September 15, 2025 Truffle Capital annonce la nomination de François Romaneix, ancien Directeur Général Adjoint de l'Institut Pasteur, en tant que Senior Partner
July 25, 2025 Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
July 24, 2025 Philippe Pouletty, CEO and co-founder of Truffle Capital and ABIVAX, is a guest on BFM TV
July 23, 2025 Excellents Résultats De Phase 3 Pour Obefazimod, Le Medicament Phare d’ABIVAX, Entreprise De Biotechnologie Fondée Par Truffle Capital
July 23, 2025 Excellent Phase 3 Results for Obefazimod, The Lead Drug From ABIVAX, A Biotech Company Founded by Truffle Capital
July 15, 2025 Caranx Medical annonce l’autorisation de mise sur le marché par la FDA de TAVIPILOT Soft
